Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441932
Max Phase: Preclinical
Molecular Formula: C53H86N2O16
Molecular Weight: 1007.27
Molecule Type: Unknown
Associated Items:
ID: ALA2441932
Max Phase: Preclinical
Molecular Formula: C53H86N2O16
Molecular Weight: 1007.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]3OC(=O)c3ccccc3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)/C(C)=C/[C@]1(C)O
Standard InChI: InChI=1S/C53H86N2O16/c1-18-37-51(9,61)25-28(2)40(56)29(3)26-52(10,62-16)45(70-49-42(58)36(54(12)13)24-30(4)64-49)31(5)43(32(6)47(59)67-37)68-38-27-53(11,63-17)46(34(8)65-38)71-50-44(39(55(14)15)41(57)33(7)66-50)69-48(60)35-22-20-19-21-23-35/h19-23,25,29-34,36-39,41-46,49-50,57-58,61H,18,24,26-27H2,1-17H3/b28-25+/t29-,30-,31+,32-,33-,34+,36+,37-,38+,39+,41-,42-,43+,44-,45-,46+,49+,50+,51+,52+,53-/m1/s1
Standard InChI Key: HDDKGHCEDWHQNQ-RPCPKYRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1007.27 | Molecular Weight (Monoisotopic): 1006.5977 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhu D, Xu Y, Liu Y, Chen X, Zhao Z, Lei P.. (2013) Synthesis of 4″-O-desosaminyl clarithromycin derivatives and their anti-bacterial activities., 23 (23): [PMID:24139585] [10.1016/j.bmcl.2013.09.083] |
Source(1):